- $14.18bn
- $13.45bn
- $2.38bn
- 97
- 25
- 90
- 80
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,574 | 1,648 | 1,921 | 2,181 | 2,378 |
Cost of Revenue | |||||
Gross Profit | 1,042 | 1,086 | 1,297 | 1,498 | 1,609 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,335 | 1,406 | 1,657 | 1,846 | 1,942 |
Operating Profit | 239 | 242 | 264 | 335 | 435 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 234 | 237 | 241 | 345 | 458 |
Provision for Income Taxes | |||||
Net Income After Taxes | 186 | 196 | 199 | 266 | 338 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 186 | 197 | 200 | 265 | 337 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 186 | 197 | 200 | 265 | 337 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.88 | 3 | 3.01 | 3.99 | 5.23 |
Dividends per Share |